Mastodawn

halama_immuno Jun 22, 2024

Also very interesting for #immunotherapy in another #cancer entity: the spatial landscapes in #RenalCellCarcinoma explored utilizing a wide range of datasets. @cyrilpedia @gpollara
https://www.nature.com/articles/s41591-024-02978-9

A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma - Nature Medicine

Multiomics and spatial mapping of tumor samples derived from a real-world cohort of patients with advanced renal cell carcinoma, as well as integration of transcriptomics and human leukocyte antigen genotyping data, provides a machine learning-derived signature of response to immune checkpoint blockade.

Nature

Benny B Jul 2, 2023

It's been awhile, and there are lots of new users on here, so time for another #introduction post.

I'm Benny from CT, USA. I'm a #CNC #ProductionManager. It's high-stress and I hate it. I've been happily married for 20 years to my wife who was recently diagnosed with #cancer. She has #RenalCellCarcinoma and is currently undergoing #immunotherapy.

We have an amazing #lesbian daughter who I enjoy going to see #LiveMusic with. Particularly #GratefulDead related bands.

🏳️‍🌈 Staunch #Ally

Phys.org Jun 22, 2023

Referenced link: https://medicalxpress.com/news/2023-06-therapy-response-patients-metastatic-renal.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-06-therapy-response-patients-metastatic-renal.html

Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1671933536817889306#m

RT by @physorg_com: Study improves prediction of therapy response in patients with metastatic #renalcellcarcinoma @JAMAOnc https://medicalxpress.com/news/2023-06-therapy-response-patients-metastatic-renal.html

Study improves prediction of therapy response in patients with metastatic renal cell carcinoma

Dr. Niklas Klümper, resident at the Department of Urology of the University Hospital Bonn (UKB) and working group leader at the Institute for Experimental Oncology (IEO), and Dr. Jonas Saal, resident at the Medical Clinic III for Hematology and Oncology of the UKB, demonstrated a significant improvement in predicting the response to therapy in metastatic renal cell carcinoma by incorporating the level of inflammation, which was assessed using two straightforward blood parameters, alongside the conventional imaging-based approach.

Medical Xpress

Liz Hiles Jun 5, 2023

#research #opportunity for #melanoma, #tnbc, #NSCLC, #RenalCellCarcinoma, #GastricCancer (#stomachcancer), #HeadAndNeckCancer, and #bladdercancer #patients and #caregivers currently living in the United States. This is a 30-minute online survey. Compensation is a $60 Amazon Gift Card.

Please sign up at the link below for more information or to see if you qualify.
.
https://rarepatientvoice.com/mirletaliz (link also in bio!)

Let's Get Started - Rare Patient Voice

Rare Patient Voice

halama_immuno May 3, 2023

Fantastic opening presentation by Samra Turaljic @[email protected] @thecrick on #immunological and molecular landscapes in #melanoma and #RenalCellCarcinoma at the #cimt2023 meeting in Mainz, Germany #HI-TRON #immunology #Immunotherapy

TumorBoardTuesday Mar 15, 2023

📢This week’s #TumorBoardTuesday is here!!

🥼@brian_rini @JVentoMD teach us choosing adjuvant therapy for #RCC
👇🏽👇🏽

📱Weigh in your answers
🧾Bring receipts
🙋Ask Q’s
📊check polls
🔁RT
👨🏻‍⚕️tag peers👨🏻‍⚕️
@MPishvaian @JohnEbbenMDPhD
#MedTwitter
---
RT @JVentoMD
@TumorBoardTues 1/17 #TumorBoardTuesday #RenalCancer #OncTwitter
68yo👨🏾
HTN
T2DM
Arthritis

✂️2022: L Radical Nephrectomy
🔬Clear cell #RenalCellCarcinoma
📏8.2 cm, Grade 2, extends int…
https://twitter.com/JVentoMD/status/1635792959328100352

Tweet / Twitter

Twitter

TumorBoardTuesday Mar 14, 2023

⏳1 hour until TONIGHT'S #TumorBoardTuesday!!⏳

🫘@brian_rini @JVentoMD bring us the background of adjuvant therapy for #RenalCellCarcinoma

🥧This pie day, grab a piece, snuggle a baby, & prepare your 🧠 with these #CME

👇🏽👇🏽👇🏽
🫘See you soon!

---
RT @TumorBoardTues
#TumorBoardTuesday
👉B4 @BrianRini & @JVentoMD🗣️adjuvant Tx for #RenalCellCarcinoma test your🧠with these CME❓
Free #CME🔗http://integrityce.com/tbt
#PreTest Q1⃣

🧐Which IO…
https://twitter.com/TumorBoardTues/status/1635601446535155713